Editor's note: This article has been updated with a comment from a Pharmsource spokesperson. Continuous glucose monitoring specialist Dexcom has identified two lots of Dexcom G7 sensors (1725204004 ...
Glucose-monitoring specialist Dexcom announced it is expanding its diabetes-management capabilities by offering direct connectivity to the Apple Watch for its G7 continuous glucose monitoring system ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announced technical ...
DexCom (NasdaqGS:DXCM) has launched Dexcom Flex, a new continuous glucose monitoring system for Type 2 diabetes patients who ...
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its ...
The best-selling real-time CGM in the world1 is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app New system has the fastest sensor warmup on ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the FDA has cleared the next-generation ...
Dexcom, the locally based maker of continuous glucose monitors for diabetes patients, is projecting billion-dollar growth into 2030, and San Diego stands to profit. The medtech company invested more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results